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Abstract
Background: Suo Quan Wan (SQW) is an effective traditional Chinese prescription on treated lower urinary tract
symptoms (LUTS), and has been proved have modulation effect on the expression of transient receptor potential
vanilloid 1 (TRPV1) in accordance with the recovery of bladder function of overactive bladder rat. This study further
investigated the mechanism of SQW modulated TRPV1 signaling and bladder function using TRPV1 knockout (KO) mice.
Methods: Study was conducted using wild type and TRPV1 KO mice. The KO animals were grouped into KO group and
SQW treated group. We applied in vivo cystometrogram recording techniques to analyze voiding control of the urinary
bladder, as well as in vitro organ bath to study bladder distension response to various compounds, which subsequently
elicited normal smooth muscle excitation. Real-time polymerase chain reaction and western blot analysis were
performed to quantify the expression of TRPV1 and P2X3 in the bladder. ATP released from bladder strips was
measured using the luciferin–luciferase ATP bioluminescence assay kit.
Results: KO preparation inhibited decrease micturition times, while micturition interval and volume were increased.
Results of urodynamic record of the TRPV1−/− mice during NS infusion showed reduced bladder pressure and
contraction which exhibited decreased response to α, β-me ATP, KCl, and carbachol and no response to CAP.
The ATP released by the TRPV1−/− mice from strips of bladder smooth muscles was significantly reduced, along with
no TRPV1 expression and reduced expression level of P2X3 in the bladder. SQW could increase ATP release in some
degree, while had no effect on TRPV1 and P2X3 expression. SQW could improve bladder pressure slightly, while make
no significantly effects on the force response to α,β-meATP, CAP, carbachol in gradient concentration, and KCl, as well
as MBC and voiding activities.
Conclusions: TRPV1 plays an important role in urinary bladder mechanosensitivity. The effective SQW is hard to play its
proper role on bladder function of mice without TRPV1.
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Background
Efficient bladder micturition is triggered primarily by
bladder afferent nerve activities and the synthesis of
somatic and autonomic efferent mechanisms that co-
ordinate detrusor contraction and sphincter relaxation
during bladder distension. The dysfunctions of these
normal pathways are probably related to lower urinary
tract storage disorders, such as urinary incontinence and
overactive bladder symptom syndrome (OAB) [1, 2]. In
the field of urology, TRPV1 has been extensively studied
for several decades. The role of TRPV1 receptors has also
been analyzed in various urinary tract pathologies. As a
pressure sensor, TRPV1 mediates stretch detection and
regulates sensory function in the bladder [3, 4]. Clinical
evidence has proven that modulating the function of
TRPV1 signaling is related to treating many lower urinary
tract symptoms (LUTS) [5, 6]. Direct or indirect stimula-
tion of afferent nerve fibers modulated afferent informa-
tion to the central nervous system (CNS), consequently
influenced bladder filling or voiding. One of the mecha-
nisms underlie TRPV1 induced increased contraction is
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the hypothesis that TRPV1 is expressed by the epithelial
cells of the transitional epithelium, and that the activation
of these TRPV1-expressing cells results in ATP release,
which consequently activates P2X3 receptors lead to
bladder smooth muscle contraction [7].
Many Chinese traditional prescription have bladder func-
tional regulation effect and have been used in the clinical
treatment of LUTS in China, Suo Quan Wan (SQW) [8]
and Ba-Wei-Di-Huang-Wan (Hachi-mi-jio-gan) [9] are the
representative prescription. SQW, which comprised A.
oxyphylla Miq, Dioscorea rhizome Thunb., and Aconitii
tuber, is speculated to have a relaxant effect on
acetylcholine-induced contraction of smooth muscles and
is used clinically in the treatment of LUTS [9]. Previously,
we used OAB model rats, in which TRPV1 was highly
expressed in the bladder, to investigated the treated effect
of SQW on OAB. Results demonstrated that the highly
expression level of TRPV1 in the bladder after induction of
BOO, decreased after treated with SQW, and showed
dose-dependent effects. Moreover, results of TRPV1 ex-
pression in the bladder are in agreement with urodynamic
change, according to the induction of OAB model and
SQW treatment. This studies have provides evidences that
treatment of SQW on the bladder function of OAB is
related to TRPV1 modulation effect [8].
Based on this previous studies, we put forward a
hypothesis that SQW modulating bladder function
maybe related with the functional interaction of TRPV1
and P2X3. Thus, we further investigated the mechanisms
of SQW on TRPV1 signaling by using TRPV1 knockout
(KO) mice. We applied in vivo cystometrogram record-
ing techniques to analyze the urinary bladder function of
TRPV1 KO mice, as well as in vitro organ bath to study
bladder distension response to various compounds,
which subsequently elicited normal smooth muscle exci-
tation. ATP released from bladder strips was measured
using the luciferin–luciferase ATP bioluminescence assay
kit. The expression of TRPV1 and P2X3 in mice bladder
was measured via real-time polymerase chain reaction
(RT-PCR) and western blot analysis. Above to further
study the mechanism of SQW on TRPV1 regulation.
Methods
Animals and experimental grouping
Adult female C57BL/6 wild type (WT, 10–12 weeks,
18–22 g, n = 10) and TRPV1 gene KO (TRPV1−/−, KO)
mice (10–12 weeks, 18–22 g), Jackson Laboratories
(n = 32), were used in this study. The TRPV1−/− KO
mice were grouped into the TRPV1 KO group, the SQW
high dosage (1170 mg/kg) treated group (SQW H), and
the SQW low dosage (585 mg/kg) treated group (SQW L),
the selection of dosage of SQW is according to our
previous studies [8]. The animals were kept in a regulated
environment, with free access to food and water, and
maintained on a 12 h:12 h light/dark cycle. No overt
difference in feeding behavior, litter size growth rate, and
body weight was observed among the four groups.
Drug preparation
In our study, the SQW was purchased from Hunan
Hansen Pharmaceutical Co. Ltd. Briefly, the process and
production are as follows, all these three components
are weighed in the ratio of 1:1:1 and well-mixed after
grinded into powder. Using appropriate distilled water
to help these powder make into pills. According to the
Chinese Pharmacopeia [10], assurance of quality control
for SQW is validated and linderane is the recorded refer-
ence standard of SQW. HPLC and TLC were used to
test these typical chemicals of SQW in our present
experiment [11] (Data submitted as Additional file 1).
Voiding stain on paper (VSOP) analysis
The mice were individually kept in metabolic cages.
Food and water were unlimited, and the mice were
allowed to adapt to the new environment for 24 h.
Urine output was measured by evaluating the surface
area of the stains on the paper used for VSOP ana-
lysis (Whatman) for 3 h after the mice were placed in
the cages. The collected papers were imaged under
ultraviolet light to visualize the urine area and
analyzed using the edge-detection function of ImageJ
software to determine the surface area of the indi-
vidually voided urine spots. The voiding volumes of
each mouse were calculated based on a calibration
curve of surface area versus fluid drops of known
volume (1 μL, 2 μL, 5 μL, 10 μL, 20 μL, 50 μL,
100 μL, 200 μL) (Fig. 1a).
Urodynamic test
Urodynamic evaluation was performed using a urody-
namic measuring device (Laborite Delphis 94-R01-BT,
Canada). Mouse were anesthetized by administration of
10 % urethane (4.0 mg/kg) [12]. The bladder was
emptied and a two-barrel Polyethylene tubing with a
heat-flared end was inserted into the dome of the
bladder and secured by a silk suture. One barrel of
the tubing was connected to a pressure transducer for
continuous measurement of intravesical pressures,
another was connected to a Harvard syringe pump
for infuse saline into the bladder. After the bladder
was emptied, cystometrography was performed using
saline infusion at 50 μL/min. Maximum voiding
pressure (MVP) and bladder pressure (BP) were then
measured. Pumping was stopped at that moment
when urine was observed at the external orifice of
the urethra. Maximum bladder capacity (MBC) was
calculated as infusion speed multiplied by time [13].
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The values for the individual mouse represent the means
of two or three voiding cycles.
In vitro experimental protocols
The mice were anesthetized with urethane (Halocarbon
Laboratories, USA), and the urinary bladder was quickly
removed at the level of the bladder neck. The bladder
body was cut open vertically and divided into strips with
identical length (1.5 mm × 5 mm). A strip was mounted
longitudinally onto a pressure transducer that was
connected online to a PowerLab 4/30 Data Acquisition
System (LABCHART 5) and to a Dual Core processor
Pentium computer for real-time monitoring of physio-
logical force. The strips were equilibrated for at least 1 h
in Krebs–Henseleit (Krebs) solution (composition: NaCl
110 mM, KCl 4.8 mM, CaCl2 2.5 mM, MgSO4 1.2 mM,
KH2PO4 1.2 mM, NaHCO3 25 mM, and dextrose
11 mM) at 37 °C with the continuous bubbling of 95 %
O2 and 5 % CO2. The strips were continuously adjusted
to a 0.5 g resting tension.
In this experiment, α,β-me ATP (100 uM) was initially
added. Then, contractile tone was measured following
the cumulative application of CAP (10 uM), carbachol
(10−8, 3 × 10−8, 10−7, 3 × 10−7, 10−6, 3 × 10−6, 10−5 M),
and KCl (100 mM). After the contractile response of
each compound reached plateau, the strips were washed
thrice and allowed to equilibrate further for 30 min be-
fore the next compounds were added.
ATP release measurements
The Krebs solution was collected after CAP was added,
and the amount of ATP in the samples was determined
using the luciferin–luciferase ATP bioluminescence
assay kit (Sigma-Aldrich Corporation, USA). To calcu-
late ATP release, the amounts detected in the samples
were corrected for total bladder volume and time.
RT-PCR
RT-PCR was performed as previously described [8].
Total RNA from the bladder tissue was isolated by a
TRIZOL reagent and reverse transcribed into cDNA
using an RT-PCR kit (Thermo Fisher Scientific, USA)
[14, 15]. The synthesized cDNA was amplified via quan-
titative RT-PCR on an ABI Prism 7500 system using
SYBR Green RT-PCR master mix reagent (Thermo
Fisher Scientific, USA). Table 1 presents the expected RT-
PCR product sizes and primers used in this study. Data
were collected and analyzed using complementary com-
puter software. Gene expression was calculated using the
2−ΔΔCt method and normalized to GAPDH expression in
each sample [15].
Western blot analysis
Western blot analysis was performed as previously de-
scribed [8]. Tissue was homogenized, and total proteins
were extracted using a total protein extraction reagent
kit [16]. Protein concentration was measured using
Pierce BCA protein assay kit (Thermo Fisher Scientific,
USA). Protein samples were separated on SDS-PAGE
gels and transferred to PVDF membranes using a
Fig. 1 a Standard curve of VSOP. The surface area is make by fluid drops of known volume (1 μL, 2 μL, 5 μL, 10 μL, 20 μL, 50 μL, 100 μL, 200 μL).
b Linear correlation between liquid volume and stained area on the filter paper within the range of 50–800 μL, r = 0.9994, y = 4830.30
x + 1586.07 (b)






GAPDH Forward primers: ggtgaaggtcggtgtgaacg 233
Reverse primers: ctcgctcctggaagatggtg
TRPV1 Forward primers: gtttacctcgtccaccctga 106
Reverse primers: agagagccatcaccatcctg
P2X3 Forward primers: tctccagcagagacatcagca 163
Reverse primers: gggagcatcttggtgaactcag
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transblotting apparatus (Bio-Rad Laboratories, USA).
Membranes were blocked with non-fat milk and subse-
quently incubated with rabbit anti-TRPV1 (1:1000;
Abcam plc, UK) or rabbit anti-P2X3 (1:1000; Abcam plc,
UK). After processing washes, the membranes were
probed with a secondary antibody (1:2000; Millipore
Corporation, USA). Protein bands were visualized using
ECL Western blot detection reagents (Bio-Rad Labora-
tories, USA). The intensity of each target protein band
was analyzed and expressed relative to β-actin density.
Data analyses
Data are expressed as means ± standard deviation of mean
(SD). For multiple comparisons, repeated-measure
ANOVA (Holm–Sidak) was used. Pairwise and non-
pairwise comparisons were performed via Student’s t-
test. Linear regression analyses were also conducted
where appropriate, and ANCOVA was used to com-
pare regression slopes and intercepts. These calcula-
tion processes were performed using SPSS 13.0 based
on the number of individuals. P < 0.05 was considered
statistically significant.
Results
Table 2 presents the results of VSOP. The standard
curve of VSOP is shown in Fig. 1b, where r = 0.9994 and
y = 4830.30 x + 1586.07. The KO mice exhibited signifi-
cant increases in micturition interval and decreases in
voiding volume and micturition times. However, neither
SQW high dosage nor low dosage treatment significantly
changed the voiding behavior of the KO mice.
During intravesical instillation with NS, the KO mice
exhibited lower bladder pressure (BP, MVP) than the
WT mice, and MBC was increased. Compared with the
KO mice, the SQW treated mice exhibited a slight
increase in bladder pressure (BP, MVP) (Fig. 2a, b),
whereas no change was observed in MBC (Fig. 2c).
The standard curve of ATP release is shown in Fig. 3b,
where r = 0.9998 and y = 2.64 x- 9.48. The ATP release
from the bladder strips of the KO mice was significantly
lower than that from the WT mice. SQW high dosage
treatment slightly increased ATP release; by contrast, no
significant difference was found after SQW low dosage
treatment (Fig. 3a).
Force response of TRPV1−/− mice bladder smooth muscle
strips to α,β-me ATP (100 uM), KCl (100 mM), and carba-
chol (10−8, 3 × 10−8, 10−7, 3 × 10−7, 10−6, 3 × 10−6, 10−5 M)
was significantly reduced (Fig. 4b, c, d), whereas no response
to CAP (10 uM) (Fig. 4a), which were observed increase the
contraction of the bladder strips of the WT mice.
According to the results of the RT-PCR and western blot
analysis (Fig. 5a, b, c, d), the TRPV1−/− mice exhibited no
TRPV1 expression and a lower expression level of P2X3 in
the bladder compared with the WT mice. Similar results
were obtained for the SQW H and the SQW L groups.
Discussion
TRPV1 was observed functions as a chemical and thermal
sensor in vivo and plays an essential role in inflammation,
nociception, and heat perception by creating a TRPV1 KO
mice model [17]. Another research of Birder et al. on mice
lacking TRPV1 receptor inhibited increased frequency of
urination and increased frequency of low-amplitude con-
tractions in such animals [4]. These observations clearly
indicate the involvement of TRPV1 receptors in the mic-
turition process, not only in pathological states, but also
in normal conditions. In previously study, the TRPV1 KO
mice inhibited attenuation of bladder pressure during
intravesical instillation with NS. And the in vitro bath
study of the bladder strips of the KO mice showed weak-
ened force response to α, β-meATP, carbachol in gradient
concentration, and KCl. But no wonder had no response
to CAP. These compounds subsequently elicited smooth
muscle strip excitation in the WT mice. Those might
drived the TRPV1 KO mice exhibited micturition interval
extension, and the decrease of micturition times within a
certain period. CAP which located on non-selective ion
channels with high permeability for Ca2+ ions is ligand of
vanilloid receptors. CAP can cause a lower threshold of
excitability of these receptors and lead to sensitization and
activation [18]. Therefore, no effect was observed in in
vitro studies of animals lacking TRPV1 receptors.
Previous study also showed that TRPV1−/− mice exhib-
ited no expression of TRPV1 in both RT-PCR and west-
ern blot analysis, along with low ATP content release
from bladder strips and low mRNA and protein expres-
sion level of P2X3. Stimuli by second messenger, such as
ATP can cause increased expression in sensory neurons
(capsaicin- sensitive fibers) leading to sensitization of
sensory fibers, consequently leads to functional disorders
of the lower urinary tract (especially urinary bladder)











WT 10 93.03 ± 18.6 2.47 ± 0.64 104.3 ± 23.7
KO 8 116.1 ± 21.7* 1.92 ± 0.76* 132.2 ± 32.1*
KO + SQW
1170 mg/kg
8 101.27 ± 35.6 2.07 ± 0.47 123.3 ± 32.1
KO + SQW
585 mg/kg
8 103.7 ± 43.6 2.12 ± 0.51 118.4 ± 36.1
* = P < 0.05; ** = P < 0.01, KO group vs. WT group. # = P < 0.05; ## = P < 0.01,
treated group vs. KO group; Student’s t-test or Mann–Whitney U-test if data
are not normally distributed
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[19]. Generally, activation with capsaicin can increase
intracellular calcium, evoke transmitter (such as ATP)
release, and elicit transient currents [4, 20], which conse-
quently activates P2X3 receptors lead to bladder smooth
muscle contraction [7]. In contract, mice lacking TRPV1
have no expression of TRPV1 in bladder, inadequate
neuron sensitivity lead to Ca2+ ions permeability
decreased and caused ATP release reduced which related
to lower P2X3 expression level. Consequently bring
down the contractility of bladder smooth muscle, which
can be observed in the in vitro study that KO mice
inhibited weakened force response to the compounds
supposed to exciting smooth muscle. And eventually
caused micturition reflex delay. This result provided
proof for the hypothesis on how TRPV1 would affect
bladder contraction.
The detailed knowledge of the TRPV1 of lower urinary
tract and its interactions appears to be of great clinical
Fig. 2 Comparisons of cystometry parameter bladder pressure (BP, MVP), and MBC of the WT, KO, SQW H, and SQW L groups. a The Comparisons of
MVP of WT, KO, SQW H, and SQW L groups. b The Comparisons of BP of WT, KO, SQW H, and SQW L groups. c The Comparisons of MBC of WT, KO,
SQW H, and SQW L groups. Values are expressed as mean ± SD. * = P < 0.05; ** = P < 0.01, KO group vs. WT group; # = P < 0.05; ## = P < 0.01, treated
group vs. KO group. Student’s t-test or Mann–Whitney U-test if data are not normally distributed
Fig. 3 The values of ATP release from the bladder strips of the WT, TRPV1−/−, SQW H, and SQW L groups are presented. Values are expressed as
mean ± SEM. * = P < 0.05; ** = P < 0.01, KO group vs. WT group. Standard curve of the ATP release measurement, where r = 0.9998 and y = 2.64 x- 9.48
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significance, as well as being a prerequisite for proper treat-
ment of functional disorders of the urinary tract [21]. In
our latest study, we have provided a part of the scientific
foundation of SQW is efficacy in recovering bladder func-
tion, which is related to the modulation of the TRPV1 ex-
pression in bladder [8]. Current study aimed to investigate
the mechanisms of SQW on modulating the function of
TRPV1 using TRPV1 KO mice. The results indicated that
SQW could not improved the voiding behavior of the KO
mice. This finding is probably related to the inconspicuous
effect on bladder pressure during intravesical instillation.
Meanwhile, the phenomenon of urodynamic parameter im-
provement among OAB rats after treatment with SQW was
not observed in mice that lacking the TRPV1 gene. Further-
more, SQW treatment did not significantly affect the force
response to α,β-meATP, CAP, carbachol in gradient
concentration, and KCl. Although the level of ATP release
slightly increased, the expression of P2X3 did not change
significantly. According to the aforementioned study, we
speculate that SQW modulates the function of TRPV1 and
eventually benefits bladder mechanosensitivity and voiding
behavior. This phenomenon is relevant with the functional
TRPV1 signal and the physiological vanilloid-sensitive affer-
ent neurons transmission.
Conclusions
The main findings of the present study are as follows.
Firstly, reduce ATP release from the bladder and P2X3
secreted from nerves of mice without TRPV1 may result
in decrease bladder pressure and voiding reflex delay
lead to micturition interval extension. Secondly, the re-
sults of SQW intervene on the TRPV1−/− mice exhibited
Fig. 4 Comparison of bladder strips from different groups in response to α, β-me ATP, CAP, and KCl; and the CRCs of carbachol. a Force response
to CAP of the WT, KO, SQW H, and SQW L groups. b Force response to α,β-me ATP of the WT, KO, SQW H, and SQW L groups. c Force response
to KCl of the WT, KO, SQW H, and SQW L groups. d CRCs of carbachol of the WT, KO, SQW H, and SQW L groups. Values are expressed as mean ± SD.
* = P < 0.05; ** = P < 0.01, KO group vs. WT group
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slightly increased ATP release along with insignificant
difference on TRPV1 and P2X3 expression and bladder
detrusor contractile activities compared with the KO
control group. Even though SQW can improve the blad-
der function in some degree, is still far more than
enough to recoverd to normal of TRPV1 KO mice.
Meanwhile, the effective SQW is hard to function nor-
mally on bladder function of mice without TRPV1.
Therefore, we speculate that the treated effect of SQW
on bladder function is related to the modulated the
TRPV1 signaling which dominated the afferent nerve
conduction and the relevant neurotransmitter secretion.
Additional file
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